Showing results (21-30 of 296) with videos related to
Sort By:
Pageof 30
Transfusion|October 9, 2025
Strategies to mitigate transfusion-associated red blood cell alloimmunization in sickle cell disease: A retrospective analysisElizabeth P Crowe, Chinelo P Onyenekwu, Jordan Ippolito, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 12, 2023
Therapeutic Plasma Exchange: Core Curriculum 2023C Elena Cervantes, Evan M Bloch, C John SperatiAmerican Journal of Clinical Pathology|October 13, 2021
Laboratory Predictors of Hemolytic Anemia in Patients With Systemic LoxoscelismJeremy W Jacobs, Lisa Bastarache, Mary Ann ThompsonBritish Journal of Haematology|March 27, 2025
The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low- and middle-income countriesJeremy W Jacobs, Luiz Amorim, France Pirenne, et al.Transfusion|July 23, 2017
How do we manage blood donors and recipients after a positive Zika screening result?Alexandra Jimenez, Beth H Shaz, Debra Kessler, et al.Transfusion|November 11, 2021
Powassan virus: What is the risk to the blood supply?Evan M Bloch, Aaron A R Tobian, Louis M KatzClinics in Laboratory Medicine|October 25, 2021
Blood Product (Donor) Noninfectious and Infectious Testing and ModificationTania Sarker, Louis M Katz, Evan M Bloch, et al.Annals of Hematology|February 16, 2023
Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccinationJeremy W Jacobs, Garrett S Booth, Brian D AdkinsBritish Journal of Haematology|January 31, 2024
Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic reviewJeremy W Jacobs, Deva Sharma, Laura D Stephens, et al.Transfusion|August 12, 2014
Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supplyAlex J Goodell, Evan M Bloch, Peter J Krause, et al.Pageof 30